DOCSLIB.ORG

Annual Technical Report: 2014

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Technical Report: 2014 Annual technical report 2014 Department of Reproductive Health and Research including UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP) Department of Reproductive Health and Research, including the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP) Annual Technical Report, 2014 WHO/RHR/15.10 © World Health Organization 2015 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-com- mercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/ licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distin- guished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Printed by the WHO Document Production Services, Geneva, Switzerland Table of contents Acronyms and abbreviations vii 1. Introduction 1 2. High-level advocacy and input to global initiatives for sexual and reproductive health 3 3. Thematic areas 11 3.1 Family planning and contraception 11 3.2 Adolescent sexual and reproductive health 29 3.3 Maternal and perinatal health 40 3.4 Preventing unsafe abortion 69 3.5 Sexually transmitted infections (STIs) and reproductive tract infections (RTIs), including multipurpose prevention technologies (MPTs) and SRH–HIV linkages 75 3.6 Cervical cancer 92 3.7 Violence against women and harmful practices, including female genital mutilation and early marriage 99 3.8 Sexual and reproductive health in humanitarian settings 110 3.9 Infertility 113 3.10 Sexual Health 123 4. Cross-cutting topics 127 4.1 Human rights and gender equality 127 4.2 Innovations 134 4.3 Biostatistics and data management 139 4.4 Advocacy and communications 142 4.5 Research project review 153 5. Research capacity strengthening, including the HRP Alliance 157 Annex A. HRP results report 2014–2015 (provisional expenditure data) 167 Annex B. Indicator report 182 Annex C. Donors 2013-2014. 202 Acronyms and abbreviations vii Acronyms and abbreviations ACS antenatal corticosteroids AHI adolescent health intervention AMR antimicrobial resistance ANC antenatal care ARV antiretroviral ASRH adolescent sexual and reproductive health ASRM American Society for Reproductive Medicine AYSRH adolescent and youth sexual and reproductive health BASTA Battling Against Syphilis – a Team Approach (listserve) BOLD Better Outcomes in Labour Difficulty (project) BV bacterial vaginosis C4-GEP Comprehensive cervical cancer control: a guide to essential practice CAF Country Accountability Framework CAPRISA Centre for AIDS Prevention and Research in Southern Africa CCM Country Coordination Mechanism CDC United States Centers for Disease Control and Prevention CEFM child, early and forced marriage CERQual Confidence in the Evidence from Reviews of Qualitative research tool CESCR Committee on Economic, Social and Cultural Rights CHAI Clinton Health Access Initiative CIRE Continuous Identification of Research Evidence CoIA Commission on Information and Accountability for Women’s and Children’s Health CONSORT Consolidated Standards of Reporting Trials CoP Communities of Practice COS controlled ovarian stimulation CRPD Committee on the Rights of Persons with Disabilities CRVS civil registration and vital statistics CSE comprehensive sexuality education DECIDE Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence framework DHS Demographic and Health Survey DMPA depot medroxyprogesterone acetate DP Depo-Provera DSMB Data Safety and Monitoring Board EC emergency contraception ECOWAS Economic Community of West African States ECSA-HC East, Central and Southern African Health Community viii Annual Technical Report 2014 EDC Education Development Center EMTCT elimination of mother-to-child transmission EOBC emergency obstetric care EPF European Parliamentary Forum EPMM Ending Preventable Maternal Mortality ERC see WHO-ERC ESSENCE Enhancing Support for Strengthening the Effectiveness of National Capacity Efforts EU European Union EVD Ebola virus disease FANC focused antenatal care FGM female genital mutilation FGM/C female genital mutilation/cutting FIGO International Federation of Gynecology and Obstetrics FIGO-RMC FIGO’s Reproductive Medicine Committee FP2020 Family Planning 2020 (an outcome of the 2012 London Summit on Family Planning) GAC Grants Approval Committee GAP Gender and Rights Advisory Panel GARPR Global AIDS Response Progress Reporting System GASP Gonococcal Antimicrobial Surveillance Programme GAVI GAVI Alliance GDG Guideline Development Group GEAS Global Early Adolescent Study GFF Global Financing Facility GIS geographic information systems GLOSS Global STI Surveillance System GRADE Grading Recommendations, Assessment, Development and Evaluation GREAT Guideline-driven, Research priorities, Evidence synthesis, Application of evidence, Network and Transfer of knowledge GRC Guidelines Review Committee GURM genito/urinary and reproductive medicine H4+ UNFPA, UNICEF, WHO, World Bank, UNAIDS, UN Women HCV hepatitis C virus HPV human papillomavirus HRP UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction; also: Human Reproduction Programme HSV herpes simplex virus IARC International Agency for Research on Cancer IBP Implementing Best Practices ICD International Statistical Classification of Diseases and Related Health Problems ICD-MM WHO Application of ICD-10 to deaths during pregnancy, childbirth and the puerperium (ICD-Maternal Mortality) Acronyms and abbreviations ix ICD-PM WHO Application of ICD-10 to perinatal deaths (ICD-Perinatal Mortality) ICMART International Committee Monitoring Assisted Reproductive Technologies ICPD International Conference on Population and Development ICSI intracytoplasmic sperm injection ICT information and communication technology iEtD interactive Evidence-to-Decision (tool) IFFS International Federation of Fertility Societies IMPRINT Improving the reporting of clinical trials of infertility treatments IMPT Initiative for Multipurpose Prevention Technologies IPPF International Planned Parenthood Federation IPU Inter-Parliamentary Union IRB Institutional Review Board IRP Implementation Research Platform IUD intrauterine device IUI intrauterine insemination IVB Immunization, Vaccines and Biologicals (WHO Department) IVF in vitro fertilization IWG Innovations Working Group KAP knowledge, attitudes and practices LID Long-term Institutional Development (grant) LMIC low- and middle-income countries LNG levonorgestrel LSHTM London School of Hygiene and Tropical Medicine M&E monitoring and evaluation MAPS mHealth for Assessment and Planning for Scale (tool) MCA Maternal, Newborn, Child and Adolescent Health (WHO Department) MCHIP Maternal and Child Health Integrated Program MCS Multicountry Survey MDG Millennium Development Goal MEC Medical eligibility criteria for contraceptive use MHTF Maternal Health Task Force MISP Minimum Initial Service Package MMEIG Maternal Mortality Estimation Interagency Group MMWG Maternal Morbidity Working Group MOH ministry of health MPHO medical products of human origin MPT multipurpose prevention technology MSI Marie Stopes International MSI Management Systems International MSM men who have sex with men mTERG Technical and Evidence Review Group on mHealth for RMNCH x Annual Technical Report 2014 NASG non-pneumatic anti-shock garment NCD noncommunicable disease NET-EN norethisterone enanthate NGO nongovernmental organization NIH United States National Institutes of Health NVI Noncommunicable Diseases, Disability, Violence and Injury Prevention (WHO Department) OHCHR Office of the UN High Commissioner for Human Rights OHSS ovarian hyper-stimulation syndrome OpenSRP Open Smart Register Platform PAHO Pan American Health Organization PCC Policy and Coordination Committee PCOS polycystic ovary syndrome PICO population, intervention, comparator and outcome PID pelvic inflammatory disease PMNCH Partnership for Maternal, Newborn and Child Health PMTCT prevention of mother-to-child transmission POCT point-of-care
Load more

Recommended publications
  • The Female Condom PATIENT EDUCATION SERIES
    The Female Condom PATIENT EDUCATION SERIES What is the female condom? • Female condoms should not be used simultane- The female condom, the first condom-like device de- ously with male condoms because the two may signed for women, was approved by the FDA in May stick together. 1993 for sale in the U.S. To remove the female condom after intercourse: It is a loose-fitting, pre-lubricated, 7-inch polyure- • Squeeze and twist the outer ring to keep the thane pouch that fits into the vagina. It is a barrier semen inside the pouch. method of birth control, which if used correctly, can • Remove it gently before you stand up. Wrap it prevent semen from being deposited in the vagina. in a tissue and throw it away in the garbage. It can also protect women against several sexually Do not flush it down the toilet. transmitted infections (STIs), including HIV, by pre- venting the exchange of fluids (semen, vaginal secre- Do not reuse female condoms. Use a new one every tions, blood) during intercourse. time you have intercourse. Be careful not to tear the condom with fingernails or sharp objects. How is it used? There is a flexible ring at the closed end of the thin, What if the female condom tears, doesn’t soft pouch. A slightly larger ring is at the open end. stay in place during sex or bunches up in- The ring at the closed end holds the condom in place side the vagina? in the vagina. The ring at the open end rests outside If a problem occurs during the use of the female the vagina.
    [Show full text]
  • A History of Birth Control Methods
    Report Published by the Katharine Dexter McCormick Library and the Education Division of Planned Parenthood Federation of America 434 West 33rd Street, New York, NY 10001 212-261-4716 www.plannedparenthood.org Current as of January 2012 A History of Birth Control Methods Contemporary studies show that, out of a list of eight somewhat effective — though not always safe or reasons for having sex, having a baby is the least practical (Riddle, 1992). frequent motivator for most people (Hill, 1997). This seems to have been true for all people at all times. Planned Parenthood is very proud of the historical Ever since the dawn of history, women and men role it continues to play in making safe and effective have wanted to be able to decide when and whether family planning available to women and men around to have a child. Contraceptives have been used in the world — from 1916, when Margaret Sanger one form or another for thousands of years opened the first birth control clinic in America; to throughout human history and even prehistory. In 1950, when Planned Parenthood underwrote the fact, family planning has always been widely initial search for a superlative oral contraceptive; to practiced, even in societies dominated by social, 1965, when Planned Parenthood of Connecticut won political, or religious codes that require people to “be the U.S. Supreme Court victory, Griswold v. fruitful and multiply” — from the era of Pericles in Connecticut (1965), that finally and completely rolled ancient Athens to that of Pope Benedict XVI, today back state and local laws that had outlawed the use (Blundell, 1995; Himes, 1963; Pomeroy, 1975; Wills, of contraception by married couples; to today, when 2000).
    [Show full text]
  • Female Condom Generic Specification, Prequalification
    Female Condom: Generic Specification, Prequalification and Guidelines for Procurement, 2012 The following organizations support the use of the WHO/UNFPA Female Condom Generic Specification: The Global Fund to Fight AIDS, Tuberculosis and Malaria FHI360 International Planned Parenthood Federation/CONtraceptive and SRH Marketing LTD (IPPF/ICON) I + Solutions Marie Stopes International (MSI) John Snow, Inc. (JSI) Joint United Nations Programme on HIV/AIDS (UNAIDS) PATH Partners in Population and Development (PPD) Population Action International Population Services International (PSI) Reproductive Health Supplies Coalition (RHSC) United Nations Population Fund (UNFPA) World Health Organization, Department of Reproductive Health and Research (WHO/RHR) Female Condom: Generic Specification, Prequalification and Guidelines for Procurement, 2012 WHO/UNFPA Female Condom Generic Specification, Prequalification and Guidelines for Procurement, 2012 © World Health Organization, United Nations Population Fund and FHI360, 2012 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications— whether for sale or for non commercial distribution—should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization and UNFPA concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundar- ies.
    [Show full text]
  • ASSIST II Participant Information Leaflet V2.0 07JUL2020.Pdf
    The BD Odon Device™ for assisted vaginal birth: A feasibility study to investigate safety and efficacy The ASSIST II Study Participant Information Leaflet Would you be willing to join us in a research project? Page 1 of 10 ASSIST II Participant Information Leaflet v2.0 (07JUL2020) The ASSIST II Study: A study investigating the use of a device that may be used to assist a baby’s birth We would like to invite you to join us in a research study investigating a new device which may be used to assist your baby’s birth. Before you decide whether you would like to participate, it is important for you to understand why the research is being performed and what it involves. There is also an ASSIST II Study video – the video and this leaflet contain different information so it is important they are used together. You will then be able to ask any questions and be given time to decide if this study is right for you and your baby. Why have I been invited to take part? All women who are pregnant with one baby and are planning a vaginal birth at either Southmead or Cossham Maternity Unit are invited to take part in this study. If you would like to take part, we would like your agreement in principle before labour, just in case you do need assistance with the birth of your baby later on. Do I have to take part? No. It is entirely up to you whether you agree to take part or not. If you decide not to be involved, your care will not be affected in any way.
    [Show full text]
  • My Changing Body: Puberty and Fertility Awareness for Young
    My Changing Body: Puberty and Fertility Awareness for Young nd People, 2 Edition A Pilot Study in Guatemala and Rwanda Submitted December 2011 The Institute for Reproductive Health Georgetown University INSTITUTE FOR REPRODUCTIVE HEALTH GEORGETOWN UNIVERSITY WWW.IRH.ORG © 2011. Institute for Reproductive Health, Georgetown University Recommended Citation: My Changing Body: Puberty and Fertility Awareness for Young People, 2nd Edition. A Pilot Study in Guatemala and Rwanda. December 2011. Washington, D.C.: Institute for Reproductive Health, Georgetown University for the U.S. Agency for International Development (USAID). The Institute for Reproductive Health (IRH) is part of the Georgetown University Medical Center, an internationally recognized academic medical center with a three-part mission of research, teaching and patient care. IRH is a leading technical resource and learning center committed to developing and increasing the availability of effective, easy-to- use, fertility awareness-based methods (FAM) of family planning. IRH was awarded the 5-year Fertility Awareness-Based Methods (FAM) Project by the United States Agency for International Development (USAID) in September 2007. This 5-year project aims to increase access and use of FAM within a broad range of service delivery programs using systems-oriented scaling up approaches. This publication was made possible through support provided by the United States Agency for International Development (USAID) under the terms of the Cooperative Agreement No. GPO-A-00-07-00003-00. The contents of this document do not necessarily reflect the views or policies of USAID or Georgetown University. The FAM Project Institute for Reproductive Health Georgetown University 4301 Connecticut Avenue, N.W., Suite 310 Washington, D.C.
    [Show full text]
  • Underrepresented Communities Historic Resource Survey Report
    City of Madison, Wisconsin Underrepresented Communities Historic Resource Survey Report By Jennifer L. Lehrke, AIA, NCARB, Rowan Davidson, Associate AIA and Robert Short, Associate AIA Legacy Architecture, Inc. 605 Erie Avenue, Suite 101 Sheboygan, Wisconsin 53081 and Jason Tish Archetype Historic Property Consultants 2714 Lafollette Avenue Madison, Wisconsin 53704 Project Sponsoring Agency City of Madison Department of Planning and Community and Economic Development 215 Martin Luther King, Jr. Boulevard Madison, Wisconsin 53703 2017-2020 Acknowledgments The activity that is the subject of this survey report has been financed with local funds from the City of Madison Department of Planning and Community and Economic Development. The contents and opinions contained in this report do not necessarily reflect the views or policies of the city, nor does the mention of trade names or commercial products constitute endorsement or recommendation by the City of Madison. The authors would like to thank the following persons or organizations for their assistance in completing this project: City of Madison Richard B. Arnesen Satya Rhodes-Conway, Mayor Patrick W. Heck, Alder Heather Stouder, Planning Division Director Joy W. Huntington Bill Fruhling, AICP, Principal Planner Jason N. Ilstrup Heather Bailey, Preservation Planner Eli B. Judge Amy L. Scanlon, Former Preservation Planner Arvina Martin, Alder Oscar Mireles Marsha A. Rummel, Alder (former member) City of Madison Muriel Simms Landmarks Commission Christina Slattery Anna Andrzejewski, Chair May Choua Thao Richard B. Arnesen Sheri Carter, Alder (former member) Elizabeth Banks Sergio Gonzalez (former member) Katie Kaliszewski Ledell Zellers, Alder (former member) Arvina Martin, Alder David W.J. McLean Maurice D. Taylor Others Lon Hill (former member) Tanika Apaloo Stuart Levitan (former member) Andrea Arenas Marsha A.
    [Show full text]
  • FIGURE 1 in Trained Hands, Operative Vaginal Delivery Can Be An
    FIGURE 1 In trained hands, operative vaginal delivery can be an extremely effective intervention to expedite delivery when nonreassuring fetal testing is noted during the second stage of labor. ILLUSTRATION: KIMBERLY MARTENS FOR OBG MANAGEMENT 38 OBG Management | June 2014 | Vol. 26 No. 6 obgmanagement.com UPDATE OPERATIVE VAGINAL DELIVERY New data confirm that the combination of forceps and vacuum extraction should be avoided and demonstrate that use of midcavity rotational forceps is safe and effective ›› Errol R. Norwitz, MD, PhD Dr. Norwitz is Louis E. Phaneuf Professor of Obstetrics and Gynecology, Tufts University School of Medicine, and Chairman of the Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts. Dr. Norwitz serves on the OBG Management Board of Editors. The author reports no financial relationships relevant to this article. he past year has seen the publica- delivery in the setting of transverse arrest, Ttion of four studies with relevance for namely manual rotation, vacuum rota- clinicians: tion, and rotational forceps • a retrospective cohort study that exam- • another retrospective cohort study that ined the maternal risks of operative vaginal compared maternal morbidity among IN THIS ARTICLE delivery using forceps, vacuum extraction operative vaginal deliveries performed by (FIGURE 1), or a combination of forceps midwives and physician providers in the Why you should learn and vacuum United Kingdom to perform midcavity • a prospective cohort study that investi- • a description of a new technique for instru- rotational deliveries gated the efficacy and safety of three dif- mental vaginal delivery that is low-cost, page 40 ferent techniques for midcavity rotational simple, and easy to perform.
    [Show full text]
  • Birth Control
    Call 311 for Women’s Healthline Free, confidential information and referrals Birth Control New York City Human Resources Administration Infoline Or visit www.nyc.gov/html/hra/pdf/medicaid-offices.pdf What’s Right for You? Information on public health insurance (including Medicaid) for family planning services Other Resources Planned Parenthood of New York City 212-965-7000 or 1-800-230-PLAN (1-800-230-7526) www.ppnyc.org National Women’s Information Center 1-800-994-WOMAN (1-800-994-9662) www.4woman.gov National Family Planning Reproductive Health Association www.nfprha.org Sexuality Information and Education Council of the United States www.siecus.org TAKE CONTROL The New York City Department of Health and Mental Hygiene Michael R. Bloomberg, Mayor Thomas R. Frieden, M.D., M.P.H., Commissioner nyc.gov/health Contents Why Use Birth Control?................................................. 2 Non-Hormonal Methods Male Condoms............................................................. 4 Female Condoms........................................................... 5 Diaphragms and Cervical Caps............................................. 6 Spermicides................................................................ 7 Copper IUDs (Intrauterine Devices)........................................ 8 Fertility Awareness and Periodic Abstinence............................... 9 Hormonal Methods Birth Control Pills (Oral Contraceptives)...................................10 The Birth Control Patch....................................................12 Vaginal
    [Show full text]
  • Curriculum Vitae
    CURRICULUM VITAE Gian Carlo Di Renzo, MD, PhD Professional Address Gian Carlo Di Renzo Professor and Chairman Dept. of Ob/Gyn Director, Centre for Perinatal and Reproductive Medicine Santa Maria della Misericordia University Hospital 06132 San Sisto - Perugia - Italy tel. +39 075 5783829 tel. +39 075 5783231 fax +39 075 5783829 [email protected] Date of birth: 13 June 1951 Place of birth: Verona, Italy Citizenship: Italian 1 Director of Education and Communication & Past General Secretary of FIGO University of Perugia, Perugia, Italy. Prof. Gian Carlo Di Renzo is currently Professor and Chair at the University of Perugia (2004 - ), and Director of the Reproductive and Perinatal Medicine Center (1996 - ) , former Director of the Midwifery School (2004-2016), University of Perugia, in addition to being the Director of the Permanent International and European School of Perinatal and Reproductive Medicine (PREIS) in Florence (2012 - ) . After graduation cum laude at Medical School of the University of Padova (1975) , he was a research fellow at the Universities of Verona, Messina and Modena. After training at CHUV in Lausanne (Switzerland), at UCH in London (UK), at the University of Texas in Dallas (USA), and at the Catholic University in Nijmegen (NL) (1977-1982), he became a senior researcher at the University of Perugia. Since 2004 he is Professor and Chairman of the Department of Obstetrics and Gynecology at the University or Perugia., Chairman of the Midwifery School in the year 2004 to 2016, of the Ob Gyn Resident’s program since 2008 and of the PhD Program in Translational Medicine since 2012. He was general Secretary of the Italian Society of Perinatal Medicine, President of the Italian Society of Ultrasound in Obstetrics and Gynecology, Secretary-Treasurer of the European Association of Perinatal Medicine, President from 2000 to 2002, 2002-2008 Executive Director and Chairman of the Educational Committee, Vice President of the World Association of Perinatal Medicine ( 2007-2013) .
    [Show full text]
  • Information About FC2 Female Condom and Its Use
    Information about FC2 Female Condom and Its Use. FC2 female condom has the same design and instructions for use as the FC1 female condom. The material has been changed to improve affordability, while maintaining the high quality, reliability and features of FC1. FC2’s sheath, with its outer ring, is made from a synthetic nitrile. Insert FC2 prior to sexual intercourse to provide protection against HIV/AIDS, other STIs and unintended pregnancies. The inner ring aids insertion and helps to secure the device in place during intercourse while the softer outer ring remains outside the vagina. FC2 female condom Like FC1, FC2 Is a new second generation Provides women and men with female condom made of an additional choice to protect synthetic nitrile. It was themselves against HIV/AIDS, designed to improve other STIs and unintended affordability, particularly in pregnancies. large volumes, while Forms a barrier between the maintaining the high quality, penis and the vagina, cervix and reliability and features of the part of the external genitalia, original FC1 female condom. thereby providing additional Has been shown in studies protection. to be comparable to FC1. Is strong, hypoallergenic and, These assessments include unlike latex, may be used with preclinical safety studies of both oil and water-based the new material and a direct lubricants. comparison study evaluating Is not dependent on the male efficacy in terms of failure erection, does not require rates (rips, tears and immediate withdrawal and is not slippage). tight or constricting. The Female Health Company Is, with FC1, the only female- Has passed a stringent technical 515 North State Street, Suite 2225 initiated protection method review process conducted by Chicago, Illinois 60654 invented and approved since WHO including safety, quality Tel: + 1 312 595 9123 the advent of the HIV/AIDS and clinical data.
    [Show full text]
  • O'brien, SM, Winter, C., Burden, CA, Boulvain, M., Draycott, TJ
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Explore Bristol Research O'Brien, S. M. , Winter, C., Burden, C. A., Boulvain, M., Draycott, T. J., & Crofts, J. F. (2017). Pressure and traction on a model fetal head and neck associated with the use of forceps, Kiwi™ ventouse and the BD Odon Device™ in operative vaginal birth: a simulation study. BJOG: An International Journal of Obstetrics and Gynaecology, 124(S4), 19-25. https://doi.org/10.1111/1471-0528.14760 Peer reviewed version License (if available): CC BY-NC Link to published version (if available): 10.1111/1471-0528.14760 Link to publication record in Explore Bristol Research PDF-document This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Wiley at http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.14760/abstract. Please refer to any applicable terms of use of the publisher. University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/about/ebr-terms Pressure and traction on a model fetal head and neck associated with the use of forceps, Kiwi™ ventouse and the BD Odon Device™ in operative vaginal birth: a simulation study Authors Stephen M O’Brien a, b, Cathy Winter a, Christy A Burden a, b, Michel Boulvain d, Tim J Draycott a, c, Joanna F Crofts a, c a Department of Obstetrics
    [Show full text]
  • An Introduction and High Yield Summary of Female Contraceptive
    Florida International University FIU Digital Commons HWCOM Faculty Publications Herbert Wertheim College of Medicine 10-24-2017 An Introduction and High Yield Summary of Female Contraceptive Methods Dharam Persaud Herbert Wertheim College of Medicine, Florida International University, [email protected] J. Burns Herbert Wertheim College of Medicine, Florida International University J. Trangle Herbert Wertheim College of Medicine, Florida International University J. Agudelo Honors College, Florida International University JA Gonzalez Honors College, Florida International University See next page for additional authors This work is licensed under a Creative Commons Attribution 4.0 License. Follow this and additional works at: https://digitalcommons.fiu.edu/com_facpub Part of the Medicine and Health Sciences Commons Recommended Citation Persaud, Dharam; Burns, J.; Trangle, J.; Agudelo, J.; Gonzalez, JA; Nunez, D.; Perez, K.; Rasch, D.; Valencia, S.; and Rao, C. V., "An Introduction and High Yield Summary of Female Contraceptive Methods" (2017). HWCOM Faculty Publications. 117. https://digitalcommons.fiu.edu/com_facpub/117 This work is brought to you for free and open access by the Herbert Wertheim College of Medicine at FIU Digital Commons. It has been accepted for inclusion in HWCOM Faculty Publications by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. Authors Dharam Persaud, J. Burns, J. Trangle, J. Agudelo, JA Gonzalez, D. Nunez, K. Perez, D. Rasch, S. Valencia, and C. V. Rao This article is available at FIU Digital Commons: https://digitalcommons.fiu.edu/com_facpub/117 Open Access Austin Journal of Reproductive Medicine & Infertility Research Article An Introduction and High Yield Summary of Female Contraceptive Methods Persaud-Sharma D1*, Burns J1, Trangle J1, Agudelo J2, Gonzalez JA2, Nunez D2, Perez K2, Abstract Rasch D2, Valencia S2 and Rao CV1,3 Globally, contraceptive studies and their use are major challenges in the 1Florida International University, Herbert Wertheim realm of public health.
    [Show full text]